Sotera Health Q3 net revenues up 10% to $249M; adjusts FY2022 guidance

Sotera Health Co

2022-Q3 EPS reported $0.31 revenue$752,097,000

Q3 net revenues $249M, up 10% YoY; constant currency growth 13.2%.
Net income $25M ($0.09 diluted EPS) vs $27M ($0.10) in Q3 2021.
Adjusted EBITDA $125M, up 7.3% YoY; Adjusted EPS $0.23, up from $0.21.
Full-year 2022 guidance revised: net revenue growth 7-8%, Adjusted EBITDA growth 4-6%.
Alex Dimitrief joined as General Counsel effective Nov 1, 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Sotera Health Co reported FY 2022 results: revenue net revenue growth 7% - 8%.

Period: FY 2022
Revenue: net revenue growth 7% - 8%
Result: guidance update

Exact text from the filing

Adjusting full-year 2022 net revenue growth outlook to 7% - 8% and Adjusted EBITDA growth to 4% - 6%

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Sotera Health Co filing history →

Source: SEC EDGAR

accession 0001822479-22-000068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.